Brian Bonnell, Chief Financial Officer of ICU Medical Inc. (), sold 6,381 shares of the company’s common stock on September 1, 2026. The shares were sold at a price of $175.00 per share, totaling $1,116,675. The transaction was executed pursuant
Christine Ortiz, a director at Mueller Water Products, Inc. (), sold shares of the company’s common stock on September 1, 2026. The transaction involved the sale of 550 shares at a price of $23.93 per share, totaling $13,161. The sale
David B. Juran, a director at Bridgewater Bancshares Inc. (), sold 518 shares of the company’s common stock on August 28, 2026. The transactions totaled $11,138, with shares sold at prices ranging from $21.50 to $21.505. The sale comes as the
Mark Alvino, a director at ABEONA THERAPEUTICS INC. (), sold 15,000 shares of common stock on September 1, 2026. The transactions totaled $87,966, with shares sold at prices ranging from $5.80 to $5.9250. Following this sale, Mr. Alvino directly holds 62,065 shares of
Robert C. Abernethy Jr., a director at Peoples Bancorp of North Carolina Inc. (), sold shares totaling $51,756 on September 1, 2026. The transaction involved the direct disposition of 1,200 shares of common stock at a price of $43.13 per share.
Mark E. Foster, Executive Vice President, General Counsel, and Secretary of (AHR), sold 2,000 shares of the company’s common stock on September 1, 2026. The transaction totaled $110,780, with shares sold at a price of $55.39 each. The sale
Wupen Yuen, President of Global Business Units at Lumentum Holdings Inc. (), recently sold shares of the company’s common stock totaling approximately $1,368,495. The transactions, which occurred between August 28, 2026, and September 1, 2026, involved the disposition of 1,500 shares
Michael Myers, Chief Executive Officer and a Director of Quoin Pharmaceuticals, Ltd. (), recently acquired 20,490 American Depositary Shares (ADSs) for a total value of $99,991. The shares were purchased at a price of $4.88 per ADS on August 31, 2026.
Sally Bridget Lawlor, Chief Financial Officer of Quoin Pharmaceuticals, Ltd. (), recently acquired company stock totaling $49,990. The transaction, reported on August 31, 2026, involved the purchase of American Depositary Shares (ADSs) as part of an issuer’s private
Michael Simanovsky, a Director and 10% owner of Sonida Senior Living, Inc. (), along with Conversant Capital LLC, reported sales of common stock totaling approximately $4.76 million. The transactions occurred on August 28 and September 1, 2026, with the volume-weighted average
